advisorsecurities master

ABEOAbeona Therapeutics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11181
Ticker
ABEO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1980-09-19
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ABEO

Detail

Enriched 2026-08-14 20:47

Market cap
$425,183,774.24
Shares outstanding (class)
56,995,144
Shares outstanding (weighted)
56,995,144
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
226
Location
CLEVELAND, OH
Description

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data